Events & Presentations
Board of Directors
Historic Stock Lookup
Click here for replay of 2017 Annual Meeting Presentation
December 15, 2017 | Presentation
2017 Corporate Update Presentation
December 14, 2017 | Presentation
Galectin Therapeutics Announces Results from Phase 2b NASH-CX Trial
December 5, 2017 | Press Release
Why did you choose to become the CEO of Galectin Therapeutics?
Are you conducting clinical trials with GR-MD-02? What results have you seen so far?
Can you give me a quick overview of Galectin Therapeutics and the opportunity it sees for GR-MD-02?
Why are the results of the GR-MD-02 psoriasis study so promising?
Why is the NASH-CX trial so important?
See all videos
Galectin Therapeutics, Inc.
Financial Tear Sheet
Filings & Reports
Stock price updates every 30 minutes.
Latest Corporate Presentation
Media Fact Sheet
© 2017 Galectin Therapeutics Inc. - All Rights Reserved
Compassionate Use Policy
Disclaimer: This site may contain